FDA recall Z-0849-2023
Biomerieux Inc · Class II · device
Product
ETEST CLINICAL IMIPENEM RELEBACTAM IPR US S30, CATALOG 420927
Reason for recall
As the temperature and time out of range was exceeded, product performances cannot be guaranteed
Distribution
US Nationwide distribution.
Key facts
- Status
- Ongoing
- Initiation date
- 2022-11-09
- Report date
- 2023-01-11
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Hazelwood, MO, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-0849-2023